Market Tracker

08/30 1:14pm ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.97
Delayed Data
As of 12:59pm ET
 +0.136 / +3.55%
Today’s Change
3.18
Today|||52-Week Range
34.40
-76.94%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close3.83
Today’s open4.50
Day’s range3.96 - 4.75
Volume791,907
Average volume (3 months)214,287
Market cap$55.9M
Dividend yield--
Data as of 12:59pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-33.65%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp+0.02+0.85%
CASICASI Pharmaceuticals...+0.02+1.74%
RNNRexahn Pharmaceutica...+0.00+1.21%
PTXPernix Therapeutics ...-0.02-2.76%
Data as of 1:12pm ET, 08/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts